22 December 2006
Oxidant-antioxidant balance in patients with psoriasis
Alina Woźniak, Gerard Drewa, Ewa Krzyżyńska-Malinowska, Rafał Czajkowski, Franciszka Protas-Drozd, Celestyna Mila-Kierzenkowska, Małgorzata Rozwodowska, Małgorzata Sopońska, Ewa Czarnecka-ŻabaMed Sci Monit 2007; 13(1): CR30-33 :: ID: 470146
Abstract
Background: Psoriasis is a chronic infl ammatory skin disease characterized by pathological skin lesions due to various exogenous and endogenous factors and associated with a number of biochemical and immunological
disturbances. Antioxidant enzymes may be involved in the pathogenesis of the disease. The aim of this study was to evaluate the concentration of lipid peroxidation products and glutathione peroxidase (GPx) activity in the blood of patients with psoriasis before and after treatment by conventional methods.
Material/Methods: The patient group consisted of 67 persons with psoriasis vulgaris who were treated at the Department and Clinic of Dermatology. The duration of the disease was from 3 to 34 years. All patients were
treated topically. The concentration of thiobarbituric acid reactive substances (TBARS) was determined in the blood plasma. The activity of GPx was determined in erythrocytes.
Results: In the healthy persons, GPx activity was 16.8±3.7 U/g Hb and TBARS concentration 0.63±0.16 nmol MDA/ml of plasma. In the psoriasis patients, GPx activity in erythrocytes was 14.8±4.3 U/g Hb and TBARS concentration was 0.73±0.22 nmol MDA/ml of plasma before treatment. The applied external
treatment caused improvement in the clinical state and a slow increase in GPx activity as well as a decrease in TBARS concentration to values comparable to those of the healthy volunteers.
Conclusions: The results suggest that disorders in antioxidant defense mechanisms may play an important role in the pathogenesis of psoriasis.
Keywords: Antioxidants - metabolism, Erythrocytes - enzymology, Glutathione Peroxidase - blood, Oxidants - metabolism, Psoriasis - metabolism, Thiobarbituric Acid Reactive Substances - analysis
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
11 Mar 2024 : Clinical Research
Enhancement of Frozen-Thawed Human Sperm Quality with Zinc as a Cryoprotective AdditiveMed Sci Monit In Press; DOI: 10.12659/MSM.942946
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952